Business
AstraZeneca COVID-19 vaccine: What triggered shutdown of vaccine hope – NEWS.com.au
AstraZeneca COVID-19 vaccine: What triggered shutdown of vaccine hope
A participant in AstraZenecas coronavirus vaccine trial triggered a global shutdown of the promising vaccine after she experienced worrying neurological symptoms.The woman’s symptoms were consistent with transverse myelitis, a serious spinal inflammatory disorder that can cause bladder problems, muscle weakness, pain and at worst, paralysis.
AstraZeneca chief executive Pascal Soriot revealed the woman’s symptoms in a private conference call with investors yesterday, information that was later s…
-
Noosa News7 hours agoPill checking to resume in Queensland months after government axed funding
-
General20 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
Noosa News16 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
General22 hours agoUS CDC boss Susan Monarez refuses to quit, defying Trump’s White House